Revvity | PKI - 营业费用

股票价格
86.80
每天变化
0.03 0.03%
每月一次
2.38%
每年
-8.69%
Q2 预测
84.91


金融业
股票价格
USD
资产
USD 12.17B
现金及等价物
USD 919.86M
销售成本
USD 350.4M
流动资产
USD 2.24B
流动负债
USD 1.33B
债务
USD 3.37B
股息收益率
0.29
EBIT
USD 145.83M
EBITDA
USD 248.91M
员工
11K
EPS每股收益
USD 1.7
股本和储备
USD 7.38B
销售毛利
USD 421.66M
债务利息支出
USD 23.51M
利息收入
USD 0.4
贷款资金
USD 2.63B
市值
USD 10.71B
净收入
USD 98.36M
营业费用
USD 626.22M
营业利润
USD 145.83M
普通股股本
USD 113.38M
PE价格收益
49.87
税前利润
USD 55.68M
销售收入
USD 772.06M
销售和管理费用
USD 251.73M
股票
USD 379.5M
贸易债权人
USD 185.46M
应收帐款人
USD 744.67M


营业费用 更改 日
Agilent USD 1.44B 27M 2025-12
Align Technology USD 822.85M 11.8M 2025-12
Bio Techne USD 241.42M 2.52M 2025-12
Bio-Rad Laboratories USD 6.74B 6.16B 2025-09
Bruker USD 900.9M 124.3M 2025-12
Celltrion KRW 724.99B 6B 2025-09
Charles River Laboratories USD 918.41M 2.49B 2025-12
Cspc Pharmaceutical CNY 5.91B 512.77M 2025-12
Danaher USD 52.95B 47.61B 2026-03
Dentsply International USD 423M 1.06B 2025-12
Deva Holding AS TRY 1.35B 178.26M 2023-09
Dianthus Therapeutics USD 69.82M 29.14M 2025-12
Divis Laboratories Ltd INR 18.32B 1.08B 2025-12
Edwards Lifesciences USD 1.13B 65.4M 2026-03
Illumina USD 903M 69M 2025-12
Intuitive Surgical USD 1.91B 89.8M 2026-03
IQVIA Holdings USD 1.69B 4.47B 2025-12
Kangmei Pharma CNY 1.39B 144.29M 2025-09
Knight Therapeutics CAD 126.9M 8.29M 2025-12
Laboratorios Farma EUR 313.62M 17.98M 2023-12
Laboratory Of America USD 3.13B 32.4M 2025-12
Malin Corporation EUR 1.1M 400K 2024-12
Medical Developments International AUD 21.61M 11.59M 2025-12
Mesa Laboratories USD 33.98M 2.03M 2024-12
Mettler Toledo International USD 777.8M 42.3M 2025-12
Myriad Genetics USD 212.8M 16.2M 2025-12
Neuren Pharmaceuticals AUD 25.23M 16.54M 2025-12
OraSure Technologies USD 40.35M 2.45M 2025-12
Organigram Holdings CAD 83.66M 24.44M 2025-12
Ovoca Bio EUR 1.16M 4.48M 2025-06
Pacific Biosciences Of California USD 97.83M 41.29M 2025-12
Pharma Mar EUR 46.87M 7.24M 2025-12
Qiagen NV USD 418.54M 23.25M 2025-12
Quest Diagnostics USD 2.5B 76M 2026-03
Quidel USD 760.9M 1.28B 2025-12
Repligen USD 177.94M 1.82M 2025-12
Revvity USD 626.22M 25.62M 2025-12
Sartorius EUR 738.4M 22.4M 2026-03
Sino Biopharmaceutical CNY 12.39B 1.26B 2025-06
Thermo Fisher Scientific USD 9.09B 821M 2026-03
Tilray USD 237.52M 17.34M 2025-09
Waters USD 661.85M 1.67B 2025-12
Zealand Pharma A/S 775.97M 265.08M 2025-12
Zz Pientze Pharmaceu CNY 1.55B 129.66M 2025-09